| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $87.13 | $24.28 | 258.81% | 164.39x | 41.87x | 11.05x | 13.34x | 1.19x | $106.92M | 1.16% | $705.78M | 6.70 | $9.32B | 1,187.57 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $31.81 | $8.30 | 283.20% | 151.48x | 72.99x | 8.95x | 18.13x | 1.29x | $39.15M | 0.94% | $220.58M | 1.69 | $4.08B | 89.83 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $72.98 | $15.89 | 359.15% | 68.21x | 61.78x | 6.73x | 8.70x | 2.00x | $182.84M | 3.23% | $654.15M | 8.43 | $5.53B | 46.08 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $227.66 | $81.37 | 179.79% | 37.32x | 34.38x | 6.33x | 22.50x | 1.28x | $793.95M | 2.61% | $1.35B | 10.14 | $31.74B | 26.91 | ||
| HALO | HALOZYME THERAPEUTICS INC | $128.01 | $71.46 | 79.14% | 35.96x | 14.20x | 9.02x | 101.22x | 0.70x | $806.22M | 5.37% | $143.54M | 1.22 | $16.51B | 22.98 | ||
| KRYS | KRYSTAL BIOTECH INC | $313.66 | $76.20 | 311.63% | 37.93x | 42.19x | 21.03x | 6.83x | 2.49x | $257.78M | 2.78% | $1.36B | 46.03 | $8.87B | 38.00 | ||
| VCEL | VERICEL CORP | $43.04 | $8.08 | 432.95% | 89.67x | 76.37x | 7.18x | 5.96x | 2.20x | $61.66M | 2.80% | $370.04M | 7.25 | $2.17B | 49.29 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $55.75 | $19.56 | 185.04% | 146.71x | 23.52x | 3.17x | 1.71x | 0.93x | $738.18M | 6.84% | $6.32B | 32.68 | $14.10B | 36.57 | ||
| RPRX | ROYALTY PHARMA PLC | $64.76 | $36.79 | 76.04% | 34.45x | 11.94x | 11.37x | 3.81x | 0.69x | $2.92B | 10.14% | $9.79B | 21.99 | $45.39B | 38.59 | ||
| TGTX | TG THERAPEUTICS INC | $54.79 | $22.62 | 142.18% | 17.79x | 53.45x | 9.71x | 13.88x | 1.98x | $17.39M | 0.22% | $604.08M | 4.26 | $8.66B | 62.17 | ||
| ADMA | ADMA BIOLOGICS INC | $11.07 | $7.04 | 57.07% | 15.37x | 13.91x | 4.93x | 6.07x | 0.90x | $116.47M | 4.61% | $408.21M | 1.79 | $2.54B | 10.90 | ||
| MDXG | MIMEDX GROUP INC | $3.85 | $1.17 | 228.27% | 96.25x | -21.37x | 1.60x | 2.60x | 1.16x | $44.50M | 7.82% | $216.00M | 1.46 | $442.54M | 19.40 | ||
| EXEL | EXELIXIS INC | $65.11 | $30.71 | 112.02% | 19.79x | 19.73x | 6.70x | 8.75x | 1.27x | $1.17B | 7.18% | $1.84B | 7.35 | $16.02B | 14.73 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $308.30 | $87.12 | 253.86% | 30.62x | 32.49x | 21.29x | 6.35x | 2.29x | $130.62M | 2.11% | $967.52M | 48.22 | $6.27B | 22.48 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $205.70 | $191.42 | 7.46% | 13.48x | 13.51x | 2.83x | 2.78x | 0.51x | $1.62B | 12.46% | $4.80B | 75.98 | $16.13B | 9.98 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $9.53 | $7.68 | 24.03% | 10.03x | 8.76x | 4.14x | 2.60x | 0.88x | $82.01M | 14.54% | $217.65M | 3.68 | $422.10M | 5.46 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $517.49 | $149.61 | 245.89% | 29.86x | 27.09x | 10.43x | 6.48x | 2.25x | $3.80B | 2.89% | $20.25B | 79.81 | $127.00B | 23.08 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $36.83 | $31.32 | 17.60% | 11.73x | 8.85x | 2.22x | 2.15x | 0.66x | $354.90M | 16.63% | $999.24M | 17.25 | $1.75B | 6.25 | ||
| UTHR | UNITED THERAPEUTICS CORP | $592.84 | $209.09 | 183.53% | 19.60x | 21.89x | 8.01x | 3.97x | 2.61x | $1.09B | 4.33% | $6.40B | 150.24 | $23.62B | 14.09 | ||
| TECH | BIO-TECHNE CORP | $72.69 | $16.47 | 341.39% | 62.13x | 34.99x | 9.33x | 5.41x | 1.97x | $263.22M | 2.32% | $2.11B | 13.52 | $11.42B | 32.86 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $807.67 | $432.47 | 86.76% | 19.26x | 13.50x | 5.34x | 2.62x | 1.02x | $3.76B | 4.53% | $31.71B | 308.48 | $83.40B | 14.51 | ||
| VCYT | VERACYTE INC | $48.20 | $11.82 | 307.91% | 33.47x | 24.85x | 6.86x | 2.79x | 2.82x | $165.99M | 4.31% | $1.39B | 17.36 | $3.61B | 25.87 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.07 | $1.40 | -23.64% | 7.64x | -2.41x | 1.32x | 1.41x | 0.43x | $19.58M | 31.59% | $44.20M | 0.76 | $13.58M | 1.78 | ||
| INCY | INCYTE CORP | $113.31 | $58.35 | 94.17% | 13.95x | 35.79x | 3.90x | 3.62x | 1.65x | $1.92B | 8.46% | $6.34B | 31.66 | $19.02B | 9.20 |